Soichiro Yamamoto

Soichiro Yamamoto

Auto-generated profile, based on publicly available information

Soichiro Yamamoto

Department of Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan.

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2019 in Surgical Case Reports
Verified
Journal Article
Open access
PDF file
HIHideki Izumi
Hideki Izumi
HYHisamichi Yoshii
Hisamichi Yoshii
RARin Abe
Rin Abe
SYSoichiro Yamamoto
Soichiro Yamamoto
MMMasaya Mukai
Masaya Mukai
HMHiroyasu Makuuchi
Hiroyasu Makuuchi
Background: Synchronous and asynchronous multiple cancers have become more pervasive in recent years despite advances in medical technologies. However, there have been only six cases (including the present case) that underwent pancreaticoduodenectomy (PD) for pancreas head cancer following surgery for esophageal cancer. PD for treating pancreas head cancer is extremely challenging; thus, the confirmation of vessel variation and selection of surgical procedures are vital. Case presentation: The patient was a 78-year-old Japanese male who was synchronously diagnosed with esophageal and cecal cancer 7 years previously at our hospital. He was admitted with densely stained and jaundiced urine and presented no remarkable family medical history. Following various examinations, surgery was performed due to the diagnosis of distal cholangiocarcinoma (pancreatic head cancer). Since the tumor was located far from the gastroduodenal artery (GDA) and no significant lymph node metastases could be found, subtotal stomach-preserving PD was performed instead of the resection of GDA with the right gastroepiploic artery (RGEA) for gastric tube blood flow preservation. The common hepatic artery (CHA) and GDA were confirmed, and RGEA diverged from GDA was identified. Subsequently, their respective tapings were preserved. The right gastric artery (RGA) was identified, taped, and preserved considering the gastric tube blood flow. The inflow area of the right gastroepiploic vein (RGEV) through gastric colic vein trunk in the superior mesenteric vein was exposed and preserved as the outflow of gastric tube blood flow. PD was completed without any complications on the shade of the gastric tube. Conclusions: This case report describes successfully preserved gastric blood flow without the resection of GDA, RGEA, RGEV, or RGA. To preserve the gastric tube, GDA inflow, RGEA, RGA, and RGEV outflow should be preserved if possible. When performing PD after tube reconstruction, it is essential to confirm the relative positions of the blood vessel, blood flow, and tumor through three-dimensional computed tomography angiography before surgery and to consider the balance between the invasiveness and optimal curability of the surgery.

8 June 2011 in Oncology Reports
Verified
Journal Article
Open access
PDF file
MMMasaya Mukai
Masaya Mukai
KKKyoko Kishima
Kyoko Kishima
MYMasashi Yamazaki
Masashi Yamazaki
HAHiromichi Aoki
Hiromichi Aoki
HIHideki Izumi
Hideki Izumi
KOKyoji Ogoshi
Kyoji Ogoshi
The 5-year relapse-free survival rate (5Y-RFS) and 5-year overall survival rate (5Y-OS) were investigated in 766 patients with stage II/III colorectal cancer (CRC). The Stage II group included 283 patients with colon cancer (CC), 40 patients with rectosigmoid junction cancer (RSC), and 74 patients with rectal cancer (RC), while the Stage III group comprised 226 patients with CC, 52 patients with RSC, and 91 patients with RC. Stage III patients with RC were further divided into 68 patients with Ra cancer (Ra, rectum/above the peritoneal reflection) and 23 patients with Rb cancer (Rb, rectum/below the peritoneal reflection). Then the 5Y-RFS and 5Y-OS were calculated for each category or subcategory. The 5Y-RFS/5Y-OS was 80.3/80.6% for Stage II patients and 63.7% (p<0.001)/66.2% (p<0.001) for Stage III patients. In the Stage II group, the survival rates were 82.9/81.2% for CC, 77.6/74.8% for RSC, and 72.9/80.5% for RC, with no significant differences between each category. In the Stage III group, the survival rates were 69.3/72.8% for CC, 71.6/77.7% for RSC, and 46.5/46.2% for RC. There was no significant difference of survival for CC vs. RSC, but significant differences were noted for CC vs. RC (p<0.001/p<0.001) and RSC vs. RC (p=0.008/p=0.007). In the Stage III group, survival rates were 71.6/77.7% for RSC, 47.6/44.8% for Ra, and 45.7/51.3% for Rb, with significant differences for RSC vs. Ra (p=0.013/p=0.005) and RSC vs. Rb (p=0.026/p=0.180), but not for Ra vs. Rb. These results suggest that Stage II/III RS cancer should be classified as colon cancer and should not be considered an independent tumor type.

20 June 2015
Verified
Journal Article
Closed access
OCOsamu Chino
Osamu Chino
HMHiroyasu Makuuchi
Hiroyasu Makuuchi
SOSoji Ozawa
Soji Ozawa
HSHideo Shimada
Hideo Shimada
TNTakayuki Nishi
Takayuki Nishi
HKHiroshi Kajiwara
Hiroshi Kajiwara

20 September 2015
Verified
Journal Article
Closed access
SYSoichiro Yamamoto
Soichiro Yamamoto
HMHiroyasu Makuuchi
Hiroyasu Makuuchi
NKNobue Kumaki
Nobue Kumaki
SOSoji Ozawa
Soji Ozawa
HSHideo Shimada
Hideo Shimada
ISIzumi Sakai
Izumi Sakai

20 June 2015
Verified
Journal Article
Closed access
OCOsamu Chino
Osamu Chino
HMHiroyasu Makuuchi
Hiroyasu Makuuchi
SOSoji Ozawa
Soji Ozawa
HSHideo Shimada
Hideo Shimada
TNTakayuki Nishi
Takayuki Nishi
HKHiroshi Kajiwara
Hiroshi Kajiwara

20 July 2012
Verified
Journal Article
Closed access
SYSeiei Yasuda
Seiei Yasuda
ITIzumi Tsuchiya
Izumi Tsuchiya
KOKazutake Okada
Kazutake Okada
ATAkira Tanaka
Akira Tanaka
TSToshiyuki Suzuki
Toshiyuki Suzuki
MNMinoru Nakui
Minoru Nakui